Clinical Efficacy of the Anti-Cytotoxic T Lymphocyte Antigen-4 (CTLA-4) Monoclonal Antibody Ipilimumab in Pretreated Metastatic Uveal Melanoma Patients

被引：0
|
作者：
Danielli, Riccardo [1 ]
Queirolow, Paola [2 ]
Testori, Alessandro [3 ]
Plummer, Ruth [6 ]
Sileni, Vanna Chiarion [4 ]
Altomonte, Maresa [1 ]
Calabro, Luana [1 ]
Di Giacomo, Anna Maria [1 ]
Ridolfi, Ruggero [5 ]
Maio, Michele [1 ]
机构：
[1] Univ Hosp ITT, Siena, Italy
[2] IST, Genoa, Italy
[3] IEO, Milan, Italy
[4] IOV, Padua, Italy
[5] IRST, Meldola, Italy
[6] Univ Newcastle, No Inst Canc Res, Newcastle Upon Tyne, Tyne & Wear, England
来源：
JOURNAL OF IMMUNOTHERAPY | 2010年 / 33卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：894 / 894
页数：1
相关论文
共 50 条
  • [1] Anti-cytotoxic T lymphocyte antigen-4 (CTLA-4) immunotherapy for the treatment of prostate cancer
    Thompson, R. Houston
    Allison, James P.
    Kwon, Eugene D.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2006, 24 (05) : 442 - 447
  • [2] Anti-cytotoxic T lymphocyte antigen-4 antibodies in melanoma
    Tosti, Giulio
    Cocorocchio, Emilia
    Pennacchioli, Elisabetta
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2013, 6 : 245 - 256
  • [3] Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4
    Attia, P
    Phan, GQ
    Maker, AV
    Robinson, MR
    Quezado, MM
    Yang, JC
    Sherry, RM
    Topalian, SL
    Kammula, US
    Royal, RE
    Restifo, NP
    Haworth, LR
    Levy, C
    Mavroukakis, SA
    Nichol, G
    Yellin, MJ
    Rosenberg, SA
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) : 6043 - 6053
  • [4] Cytotoxic T lymphocyte antigen-4 (CTLA-4) polymorphism in patients with Behcet's disease
    Duzgun, N.
    Duman, T.
    Keskin, O.
    Morris, Y.
    Tutkak, H.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (04) : S100 - S100
  • [5] A dose escalation phase 1 study of radiotherapy (RT) in combination with anti-cytotoxic-T-lymphocyte-associated antigen 4 (CTLA-4) monoclonal antibody ipilimumab (Ipi) in patients (pts) with metastatic melanoma
    Boutros, C.
    Mateus, C.
    Routier, E.
    Chouaib, S.
    Libenciuc, C.
    Reigneau, M.
    Girault, I.
    Caramella, C.
    Hibat, S.
    Vagner, S.
    Tao, Y. G.
    Chaput, N.
    Adam, J.
    Soria, J-C.
    Eggermont, A.
    Deutsch, E.
    Robert, C.
    ANNALS OF ONCOLOGY, 2016, 27
  • [6] Cytotoxic T lymphocyte antigen-4 (CTLA-4) as a therapeutic Target in Tumor immunotherapy
    Jaeger, D.
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2012, 62 : S9 - S10
  • [7] Influence of cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms in periodontitis
    Houshmand, B.
    Rafiei, A.
    Hajilooi, M.
    ARCHIVES OF ORAL BIOLOGY, 2012, 57 (09) : 1218 - 1224
  • [8] Association of Cytotoxic T-Lymphocyte Antigen-4 (CTLA-4) Genetic Variants with Risk and Outcome of Cutaneous Melanoma
    Ferreira, Ana Maria Castro
    Carron, Juliana
    Gomez, Gabriela Vilas Boas
    Vazquez, Vinicius de Lima
    Serrano, Sergio Vicente
    Lourenco, Gustavo Jacob
    Lima, Carmen Silvia Passos
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (22)
  • [9] Targeting cytotoxic T-lymphocyte antigen-4 (CTLA-4) - A novel strategy for the treatment of melanoma and other malignancies
    O'Day, Steven J.
    Hamid, Omid
    Urba, Walter J.
    CANCER, 2007, 110 (12) : 2614 - 2627
  • [10] Sarcoidosis complicating anti-cytotoxic T-Iymphocyte-associated antigen-4 monoclonal antibody biotherapy
    Tissot, Claire
    Carsin, Ania
    Freymond, Nathalie
    Pacheco, Yves
    Devouassoux, Gilles
    EUROPEAN RESPIRATORY JOURNAL, 2013, 41 (01) : 246 - 247
12345